Frequent inactivation of RASSF1A, BLU, and SEMA3B on 3p21.3 by promoter hypermethylation and allele loss in non-small cell lung cancer

Masao Ito, Genshi Ito, Masashi Kondo, Mika Uchiyama, Takayuki Fukui, Shoichi Mori, Hiromu Yoshioka, Yuichi Ueda, Kaoru Shimokata, Yoshitaka Sekido

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Non-small cell lung cancer frequently shows loss of heterozygosity of the chromosome 3p21.3 region and several genes such as RASSF1A, BLU, and SEMA3B have been identified as candidate tumor suppressor genes at this region since their downregulation and hypermethylation at their promoter regions were frequently detected in lung cancer. To determine whether these three genes are simultaneously inactivated during lung cancer development, we studied 138 primary non-small cell lung cancers for the promoter methylation status of these genes and allelic loss of the chromosome 3p21.3 region. We found promoter hypermethylation at 32% in RASSF1A, 30% in BLU, and 47% in SEMA3B. Allelic loss of 3p21.3 was detected in 54 (58%) of 93 informative tumors. Despite the weak association of methylation status among these three genes, there was no correlation between the methylation status of each gene and loss of heterozygosity. We also studied possible genes downstream of RASSF1A in 16 primary non-small cell lung cancers and found that the expressions of SM22 and SPARC were significantly downregulated in RASSF1A-hypermethylated tumors. Our results showed that, while candidate tumor suppressor genes at this locus can be simultaneously inactivated by epigenetic alterations, loss of heterozygosity without any hypermethylation of the three genes can also occur in some cases, suggesting that just one allelic loss might also be sufficient for the inactivation of any of these genes for lung cancer development.

Original languageEnglish
Pages (from-to)131-139
Number of pages9
JournalCancer Letters
Volume225
Issue number1
DOIs
Publication statusPublished - 08-07-2005

Fingerprint

Loss of Heterozygosity
Non-Small Cell Lung Carcinoma
Alleles
Genes
Methylation
Lung Neoplasms
Tumor Suppressor Genes
Down-Regulation
Chromosomes
Gene Silencing
Genetic Promoter Regions
Epigenomics
Neoplasms

All Science Journal Classification (ASJC) codes

  • Cancer Research
  • Molecular Biology
  • Oncology

Cite this

Ito, Masao ; Ito, Genshi ; Kondo, Masashi ; Uchiyama, Mika ; Fukui, Takayuki ; Mori, Shoichi ; Yoshioka, Hiromu ; Ueda, Yuichi ; Shimokata, Kaoru ; Sekido, Yoshitaka. / Frequent inactivation of RASSF1A, BLU, and SEMA3B on 3p21.3 by promoter hypermethylation and allele loss in non-small cell lung cancer. In: Cancer Letters. 2005 ; Vol. 225, No. 1. pp. 131-139.
@article{e7513cfd5ef9430fb536c2e73076228c,
title = "Frequent inactivation of RASSF1A, BLU, and SEMA3B on 3p21.3 by promoter hypermethylation and allele loss in non-small cell lung cancer",
abstract = "Non-small cell lung cancer frequently shows loss of heterozygosity of the chromosome 3p21.3 region and several genes such as RASSF1A, BLU, and SEMA3B have been identified as candidate tumor suppressor genes at this region since their downregulation and hypermethylation at their promoter regions were frequently detected in lung cancer. To determine whether these three genes are simultaneously inactivated during lung cancer development, we studied 138 primary non-small cell lung cancers for the promoter methylation status of these genes and allelic loss of the chromosome 3p21.3 region. We found promoter hypermethylation at 32{\%} in RASSF1A, 30{\%} in BLU, and 47{\%} in SEMA3B. Allelic loss of 3p21.3 was detected in 54 (58{\%}) of 93 informative tumors. Despite the weak association of methylation status among these three genes, there was no correlation between the methylation status of each gene and loss of heterozygosity. We also studied possible genes downstream of RASSF1A in 16 primary non-small cell lung cancers and found that the expressions of SM22 and SPARC were significantly downregulated in RASSF1A-hypermethylated tumors. Our results showed that, while candidate tumor suppressor genes at this locus can be simultaneously inactivated by epigenetic alterations, loss of heterozygosity without any hypermethylation of the three genes can also occur in some cases, suggesting that just one allelic loss might also be sufficient for the inactivation of any of these genes for lung cancer development.",
author = "Masao Ito and Genshi Ito and Masashi Kondo and Mika Uchiyama and Takayuki Fukui and Shoichi Mori and Hiromu Yoshioka and Yuichi Ueda and Kaoru Shimokata and Yoshitaka Sekido",
year = "2005",
month = "7",
day = "8",
doi = "10.1016/j.canlet.2004.10.041",
language = "English",
volume = "225",
pages = "131--139",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

Ito, M, Ito, G, Kondo, M, Uchiyama, M, Fukui, T, Mori, S, Yoshioka, H, Ueda, Y, Shimokata, K & Sekido, Y 2005, 'Frequent inactivation of RASSF1A, BLU, and SEMA3B on 3p21.3 by promoter hypermethylation and allele loss in non-small cell lung cancer', Cancer Letters, vol. 225, no. 1, pp. 131-139. https://doi.org/10.1016/j.canlet.2004.10.041

Frequent inactivation of RASSF1A, BLU, and SEMA3B on 3p21.3 by promoter hypermethylation and allele loss in non-small cell lung cancer. / Ito, Masao; Ito, Genshi; Kondo, Masashi; Uchiyama, Mika; Fukui, Takayuki; Mori, Shoichi; Yoshioka, Hiromu; Ueda, Yuichi; Shimokata, Kaoru; Sekido, Yoshitaka.

In: Cancer Letters, Vol. 225, No. 1, 08.07.2005, p. 131-139.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Frequent inactivation of RASSF1A, BLU, and SEMA3B on 3p21.3 by promoter hypermethylation and allele loss in non-small cell lung cancer

AU - Ito, Masao

AU - Ito, Genshi

AU - Kondo, Masashi

AU - Uchiyama, Mika

AU - Fukui, Takayuki

AU - Mori, Shoichi

AU - Yoshioka, Hiromu

AU - Ueda, Yuichi

AU - Shimokata, Kaoru

AU - Sekido, Yoshitaka

PY - 2005/7/8

Y1 - 2005/7/8

N2 - Non-small cell lung cancer frequently shows loss of heterozygosity of the chromosome 3p21.3 region and several genes such as RASSF1A, BLU, and SEMA3B have been identified as candidate tumor suppressor genes at this region since their downregulation and hypermethylation at their promoter regions were frequently detected in lung cancer. To determine whether these three genes are simultaneously inactivated during lung cancer development, we studied 138 primary non-small cell lung cancers for the promoter methylation status of these genes and allelic loss of the chromosome 3p21.3 region. We found promoter hypermethylation at 32% in RASSF1A, 30% in BLU, and 47% in SEMA3B. Allelic loss of 3p21.3 was detected in 54 (58%) of 93 informative tumors. Despite the weak association of methylation status among these three genes, there was no correlation between the methylation status of each gene and loss of heterozygosity. We also studied possible genes downstream of RASSF1A in 16 primary non-small cell lung cancers and found that the expressions of SM22 and SPARC were significantly downregulated in RASSF1A-hypermethylated tumors. Our results showed that, while candidate tumor suppressor genes at this locus can be simultaneously inactivated by epigenetic alterations, loss of heterozygosity without any hypermethylation of the three genes can also occur in some cases, suggesting that just one allelic loss might also be sufficient for the inactivation of any of these genes for lung cancer development.

AB - Non-small cell lung cancer frequently shows loss of heterozygosity of the chromosome 3p21.3 region and several genes such as RASSF1A, BLU, and SEMA3B have been identified as candidate tumor suppressor genes at this region since their downregulation and hypermethylation at their promoter regions were frequently detected in lung cancer. To determine whether these three genes are simultaneously inactivated during lung cancer development, we studied 138 primary non-small cell lung cancers for the promoter methylation status of these genes and allelic loss of the chromosome 3p21.3 region. We found promoter hypermethylation at 32% in RASSF1A, 30% in BLU, and 47% in SEMA3B. Allelic loss of 3p21.3 was detected in 54 (58%) of 93 informative tumors. Despite the weak association of methylation status among these three genes, there was no correlation between the methylation status of each gene and loss of heterozygosity. We also studied possible genes downstream of RASSF1A in 16 primary non-small cell lung cancers and found that the expressions of SM22 and SPARC were significantly downregulated in RASSF1A-hypermethylated tumors. Our results showed that, while candidate tumor suppressor genes at this locus can be simultaneously inactivated by epigenetic alterations, loss of heterozygosity without any hypermethylation of the three genes can also occur in some cases, suggesting that just one allelic loss might also be sufficient for the inactivation of any of these genes for lung cancer development.

UR - http://www.scopus.com/inward/record.url?scp=21144446552&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21144446552&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2004.10.041

DO - 10.1016/j.canlet.2004.10.041

M3 - Article

VL - 225

SP - 131

EP - 139

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 1

ER -